Welcome, Guest. Please login or register.
March 28, 2024, 09:16:29 am

Login with username, password and session length


Members
Stats
  • Total Posts: 772945
  • Total Topics: 66310
  • Online Today: 377
  • Online Ever: 5484
  • (June 18, 2021, 11:15:29 pm)
Users Online
Users: 1
Guests: 356
Total: 357

Welcome


Welcome to the POZ Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Do I Have HIV?” posting guidelines. Click here for posting guidelines pertaining to all other POZ community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Today is HIV Vaccine Awareness Day  (Read 3252 times)

0 Members and 1 Guest are viewing this topic.

Offline Sheri

  • Member
  • Posts: 32
Today is HIV Vaccine Awareness Day
« on: May 18, 2009, 01:24:11 pm »
Please read the following forward from NIH and NIAD regarding HIV Vaccine Awareness Day.  Thanks, Sheri




HIV VACCINE AWARENESS DAY, MAY 18, 2009


U.S. Department of Health and Human Services
NATIONAL INSTITUTES OF HEALTH NIH News
National Institute of Allergy and Infectious Diseases (NIAID)
<http://www.niaid.nih.gov>

CONTACT: NIAID Office of Communications, 301-402-1663, <e-mail:niaidnews@niaid.nih.gov>

STATEMENT OF ANTHONY S. FAUCI, M.D., DIRECTOR, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, NATIONAL INSTITUTES OF HEALTH, ON HIV VACCINE AWARENESS DAY, MAY 18, 2009

On this 12th annual HIV Vaccine Awareness Day, we reaffirm our commitment to the research needed to develop a safe and effective HIV vaccine.

People continue to become infected with HIV at an alarming rate. An estimated 2.7 million new HIV infections occurred worldwide in 2007 alone. Here in the United States, about 56,000 new HIV infections occur annually -- a figure that has remained fairly consistent for more than a decade. Although antiretroviral medicines have enabled individuals infected with HIV to live longer, healthier lives, no one with HIV has ever been truly cured of the infection, and people with HIV continue to die of AIDS-related diseases in unacceptably high numbers in rich and poor countries alike.

Historically, vaccines have eliminated or greatly reduced the burden of many viral diseases, including smallpox, polio, measles, and yellow fever. HIV, however, presents unique and significant scientific obstacles that have made vaccine development particularly daunting. Most importantly, people are unable to mount an effective immune system response that clears HIV infection. This is likely because of the ability of HIV to rapidly invade and hide in host cells, and elude detection by normal immune system responses; its extraordinary capacity to mutate and evolve; and its destruction or disabling of critical immune system cells. While extremely rare, some individuals do develop antibodies that effectively neutralize HIV, but investigational vaccines so far have not induced these antibodies in a large number of people.

Recognizing these challenges and working to build upon disappointing clinical trial outcomes, NIAID in 2008 hosted a scientific summit where we committed to placing a greater emphasis on the fundamental research needed to unlock the mysteries of the human immune system and HIV infection. Since that time, we have launched several basic research-focused initiatives and studies that are beginning to produce interesting insights that may help us design future HIV vaccines. At the same time, we continue to test promising vaccine candidates in clinical trials when scientifically appropriate.

Although vaccines will continue to play a prominent role in NIAID's broad and multifaceted HIV prevention research agenda, other new prevention approaches are in advanced testing. These include microbicide gels or creams that can be applied prior to sexual intercourse and pre-exposure prophylaxis-the use of antiretroviral medicines in people who are not infected with HIV but who are at high risk for infection. Another important prevention concept is universal, voluntary HIV testing and treatment for those who test positive. One recent model suggests that such a test-and-treat program could reduce HIV infection rates by 95 percent within 10 years. NIAID is evaluating critical research questions that underpin the validity of this voluntary approach.

Our hope is that the development of an HIV vaccine and other advances in HIV prevention research will become part of a comprehensive HIV prevention toolkit that will markedly decrease new infections, even as we continue to expand our efforts to find a cure for HIV/AIDS.

Finally, today we specifically wish to thank the thousands of volunteers, scientists, community members and health professionals who have participated in HIV vaccine research and who continue to support and participate in this extremely important research effort. With your help and continued dedication, we will win the fight against HIV.

Dr. Fauci is director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health in Bethesda, Maryland.

Media inquiries can be directed to the NIAID Office of Communications at 301-402-1663, <e-mail:niaidnews@niaid.nih.gov>.

NIAID conducts and supports research -- at NIH, throughout the United States, and worldwide -- to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at <http://www.niaid.nih.gov>.

The National Institutes of Health (NIH) -- The Nation's Medical Research Agency -- includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit <www.nih.gov>.


 


Terms of Membership for these forums
 

© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.